-
Killing Cancer With Synthetic Lethality
Clinical Research News | A key member of the team that discovered the BRCA2 breast cancer susceptibility gene in 1995 is now enamored of the idea of taking on cancer with synthetic lethal therapies, a nontraditional approach that exploits the weaknesses of cancer cells. The promise of the treatment concept was the topic of the Heath Memorial Award keynote address delivered at the recent Leading Edge of Cancer Research Symposium of the University of Texas MD Anderson Cancer Center.
Dec 13, 2022
-
2023 Participant Engagement Awards Finalists Named
Clinical Research News | Finalists have been named for the 7th Annual Participant Engagement Award. Winners will be announced after a live presentation and judging session at the Summit for Clinical Ops Executives. This year’s SCOPE Summit will be held February 6-9, 2023, in Orlando, Fla.
Dec 8, 2022
-
Dr. Loaiza-Bonilla on Massive Bio’s Efforts to Make Clinical Trials More Accessible for Cancer Patients
Clinical Research News | In the latest episode of the Scope of Things podcast, host Deborah Borfitz speaks with Dr. Arturo Loaiza-Bonilla, co-founder and chief medical officer of Massive Bio, about increasing clinical trial access for cancer patients and offering next-generation enrollment services.
Dec 6, 2022
